Abstract:
Compounds of the formula ##STR1## wherein X and R.sub.1 are each chlorine or bromine;R.sub.2 is isopropyl; tert.butyl; tert.pentyl; mono-, di- or tri-hydroxy-substituted branched alkyl of 3 to 5 carbon atoms; cyclohexyl; or hydroxycyclohexyl; andR.sub.3 is alkyl of 1 to 4 carbon atoms or, when R.sub.2 is other than cyclohexyl, also hydrogen;And non-toxic, pharmacologically acceptable acid addition salts thereof; the compounds as well as their salts are useful as secretolytics, antitussives, anti-ulcerogenics and stimulants for the production of the surfactant or antiatelectasis factor of the alveoli.
Abstract:
An electrical glass melting furnace having a refractory tank, wherein the batch glass is fed onto the surface of a bath of molten glass therein and refined glass is withdrawn from a lower portion thereof. Electric heating power is supplied, in the form of three-phase AC, through two levels of peripherally spaced electrodes. The secondary coils of the transformers employed each feed an electrode or electrode pair and the output of each secondary coil is additionally connected to the input of one of the other secondary coils in the system.
Abstract:
The present invention relates to a method for indirectly heating glass-carrying channels or passages, feeders and feeder heads, and to an apparatus for carrying out such method.
Abstract:
Pharmaceutical dosage unit compositions containing as an active ingredient a compound of the formula ##STR1## wherein R.sub.1 is hydrogen, lower alkanoyl, benzoyl or halobenzoyl,R.sub.2 is hydrogen, chlorine or bromine,R.sub.3 is carboxyl or lower carbalkoxy, andR.sub.4 and R.sub.5 are each hydrogen, alkyl of 1 to 5 carbon atoms, mono- or di-hydroxy-(alkyl of 1 to 5 carbon atoms), alkenyl or 2 to 4 carbon atoms, cycloalkyl of 5 to 7 carbon atoms, mono- or di-hydroxy-(cycloalkyl of 5 to 7 carbon atoms) or benzyl,Or a non-toxic, pharmacologically acceptable acid addition salt thereof; and a method of using the same as anti-ulcerogenics, secretolytics, antitussives, and stimulants of the production of the surfactant or antiatelectasis factor of the alveoli.
Abstract:
The present invention relates to modified amino acids of general formula wherein A, Z, X, n, m, R, R2, R3, R4 and R11 are defined as in claims 1 to 5, their tautomers, their diastereomers, their enantiomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, pharmaceutical compositions containing these compounds, the use thereof and processes for preparing them as well as their use for the production and purification of antibodies and as labelled compounds in RIA- and ELISA assays and as diagnostic or analytical aids in neurotransmitter research.
Abstract:
In a glass melting furnace, a radiation screen wall is installed between a melting area and a refining area with a refining bank. This radiation screen wall leaves a flow path above the melt surface of the glass bath for the return flow of at least part of the combustion gases from the refining area to the melting area. In order to suppress a return flow of already refined and very hot glass melt from the refining area into a melting area, but still allow the charging material to melt completely as early as possible, the furnace is operated to produce at least one upward current between the middle of the melting area and the front face of the refining bank in the glass melt. Within the glass melt and before the melt surface is reached, this upward current is divided into a first partial current which flows upstream into the melting area and a second partial current which flows downstream over the refining bank, whereby a return current of the glass melt from the refining area into the melting area is prevented by the second partial current flowing downstream. This upward current is achieved by the use of one or more of the following arrangements: a row of bubblers; a step projecting upwards from the furnace bottom; and/or at least two heating electrodes which are installed before the front face of the refining bank.
Abstract:
The invention relates to cyclic derivatives of general formula ##STR1## wherein R.sub.a, R.sub.b, X and Y are as defined in claim 1, the tautomers, the stereoisomers including the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with organic or inorganic acids or bases, which have valuable pharmacological properties, preferably aggregation-inhibiting effects, pharmaceutical compositions containing the compounds and processes for preparing them.
Abstract:
The invention relates to biphenyl derivatives of general formula ##STR1## wherein A to E and X are defined as in claim 1, the stereoisomers thereof, including their mixtures and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, which have valuable properties, preferably aggregation-inhibiting effects, pharmaceutical compositions containing these compounds and processes for preparing them.
Abstract:
An electrically heated tank furnace is used to melt glass whereby a floating gall layer is formed on the melt, in particular during the vitrification of hazardous materials such as asbestos, fly ash, filter dust, whereby the tank of the furnace is fitted with a discharge outlet for the melt and an overflow channel with an inlet for the gall. A stream of ascending gas bubbles is produced in the melt. In order to promote better and automatic draining of the gall the stream of gas bubbles is produced directly in front of the overflow channel which thereby maintains a layer of liquid gall in the overflow channel and a layer of molten glass retained by a weir on the bottom of the overflow channel. The temperature in the overflow channel is chosen to be above the melting temperature of the gall, whilst the bottom layer of glass is maintained at a temperature at which the viscosity of the glass is so high that the glass does not drain out the overflow channel.